Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Iscience|August 23, 2023
Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concernYu Onodera, Jady Liang, Yuchong Li, et al.The EMBO Journal|August 10, 2021
Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sitesDavid Hoffmann, Stefan Mereiter, Yoo Jin Oh, et al.Cell Reports|May 11, 2016
The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell FateLuigi Tortola, Roberto Nitsch, Mathieu J M Bertrand, et al.Plos One|July 11, 2022
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizerRobert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.Biorxiv : the Preprint Server for Biology|September 21, 2021
Development of a novel, pan-variant aerosol intervention for COVID-19Robert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.EMBO Molecular Medicine|August 2, 2022
FIBCD1 is an endocytic GAG receptor associated with a novel neurodevelopmental disorderChristopher W Fell, Astrid Hagelkruys, Ana Cicvaric, et al.Cell Research|June 1, 2016
RANKL/RANK control Brca1 mutation-Verena Sigl, Kwadwo Owusu-Boaitey, Purna A Joshi, et al.EMBO Molecular Medicine|July 5, 2022
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variantsVanessa Monteil, Brett Eaton, Elena Postnikova, et al.Nature|August 1, 2019
Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancerShane J F Cronin, Corey Seehus, Adelheid Weidinger, et al.Nature|November 9, 2018
The metabolite BH4 controls T cell proliferation in autoimmunity and cancerShane J F Cronin, Corey Seehus, Adelheid Weidinger, et al.Pageof 4